Mediation of Polygenic Asthma Risk Through Gene Expression
Authors:
Open Access
Abstract
Background: Existing asthma polygenic risk scores (PRSs) have minimal validation in African‐ancestry populations, leaving gaps in our understanding of the wide applicability of PRSs. To widen our understanding of the applicability of asthma PRSs, we apply published PRSs in African‐ancestry individuals and quantify the extent to which the PRS‐asthma relationship is mediated by clinical biomarkers and gene‐expression signatures of asthma. Methods: We applied 22 PRSs from the PGS Catalog in 673 individuals from the Consortium on Asthma among African‐Ancestry Populations in the Americas (CAAPA) and calculated the percent of the PRS‐asthma relationship that is statistically mediated by clinical and nasal epithelium transcriptomic biomarkers of asthma. Asthma case/control status was defined as ever/never having a doctor's diagnosis of disease. For gene expression mediation analysis, we limited the cases to those with current disease. Results: The PRS (PGS001782) created by the Global Biobank Meta‐analysis Initiative ( N = 32,658 individuals of African ancestry) performed the best (ΔAUC = 0.104, AUC = 0.657) adjusted for age, sex, study site, and the first two genetic principal components (PC1‐2). The PRS's effect on asthma was mediated by total IgE (tIgE) (38.8%, p .adj < 0.0002), multi‐allergen ImmunoCAP phadiatop specific IgE (sIgE) (38.7%, p .adj < 0.0002), and eosinophils (7.3%, p .adj = 0.004). Mediation was observed for gene expression modules related to T2 inflammation (21.9%, p .adj < 0.0024), wound healing (11.9%, p .adj = 0.008), and medication response (6.8%, p .adj = 0.049). Conclusion: We found the best PRS to be the one derived using the largest sample size and including African‐ancestry individuals. Mediation supports the well‐documented biology of T2 inflammation in asthma as well as pathophysiological components of asthma like wound healing and medication response.Keywords
Funding Information
- National Institute of Allergy and Infectious Diseases
- National Heart, Lung, and Blood Institute
This publication has 49 references indexed in Scilit:
- Global Biobank analyses provide lessons for developing polygenic risk scores across diverse cohortsCell Genomics, 2023
- Systematic comparison of family history and polygenic risk across 24 common diseasesThe American Journal of Human Genetics, 2022
- Clinical and transcriptomic features of persistent exacerbation‐prone severe asthma in U‐BIOPRED cohortClinical and Translational Medicine, 2022
- Genetic risk scores do not improve asthma prediction in childhoodJournal of Allergy and Clinical Immunology, 2019
- Shared and distinct genetic risk factors for childhood-onset and adult-onset asthma: genome-wide and transcriptome-wide studiesThe Lancet Respiratory Medicine, 2019
- Genetic Architectures of Childhood- and Adult-Onset Asthma Are Partly DistinctThe American Journal of Human Genetics, 2019
- Understanding Asthma Phenotypes, Endotypes, and Mechanisms of DiseaseClinical Reviews in Allergy & Immunology, 2018
- Dissecting childhood asthma with nasal transcriptomics distinguishes subphenotypes of diseaseJournal of Allergy and Clinical Immunology, 2014
- African Ancestry is a Risk Factor for Asthma and High Total IgE Levels in African Admixed PopulationsGenetic Epidemiology, 2013
- Development and validation of the Composite Asthma Severity Index—an outcome measure for use in children and adolescentsJournal of Allergy and Clinical Immunology, 2012